SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5h7n'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E06_A_IPBA600_0 (ODORANT-BINDING PROTEIN)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	4 / 6	VAL A 9 VAL A 51 ILE A 61 ASN A 268	None	0.91A	1e06A-5h7nA: undetectable	1e06A-5h7nA: 15.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KGL_A_RTLA175_1 (CELLULAR RETINOL-BINDING PROTEIN TYPE I)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	4 / 7	LEU A 305 ILE A 330 THR A 94 MET A 322	None	1.22A	1kglA-5h7nA: undetectable	1kglA-5h7nA: 13.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_A_VIAA901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 11	ALA A 304 ILE A 109 VAL A 98 LEU A 77 ILE A 80	None	1.26A	2h42A-5h7nA: undetectable	2h42A-5h7nA: 21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_C_VIAC903_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	LEU A 263 ILE A 109 VAL A 98 LEU A 77 ILE A 80	None	0.95A	2h42C-5h7nA: undetectable	2h42C-5h7nA: 21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD2_A_CHDA426_0 (FERROCHELATASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	4 / 4	LEU A 382 PRO A 418 LEU A 390 ARG A 447	None EDO A 506 (-4.1A) None None	1.38A	2qd2A-5h7nA: undetectable	2qd2A-5h7nA: 20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VE3_A_REAA1445_1 (PUTATIVE CYTOCHROME P450 120)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	ALA A 265 LEU A 281 PHE A 280 VAL A 294 GLY A 17	None	1.11A	2ve3A-5h7nA: undetectable	2ve3A-5h7nA: 22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZW9_A_SAMA801_1 (LEUCINE CARBOXYL METHYLTRANSFERASE 2)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	4 / 8	THR A 94 LEU A 286 ASP A 288 GLU A 112	None None None MTT A 501 (-2.9A)	1.07A	2zw9A-5h7nA: undetectable	2zw9A-5h7nA: 20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BGD_A_PM6A301_1 (THIOPURINE S-METHYLTRANSFERASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	4 / 6	PHE A 259 ALA A 163 LEU A 248 PRO A 160	EDO A 505 (-4.9A) None None None	0.98A	3bgdA-5h7nA: undetectable	3bgdA-5h7nA: 19.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_C_SVRC507_1 (PHOSPHOLIPASE A2)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	4 / 7	VAL A 111 GLY A 301 PRO A 230 LYS A 306	None	0.72A	3bjwC-5h7nA: undetectable	3bjwC-5h7nA: 15.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GV1_A_BEZA302_0 (DISULFIDE INTERCHANGE PROTEIN)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	4 / 6	PRO A 127 LEU A 148 ALA A 224 PRO A 126	None	1.34A	3gv1A-5h7nA: undetectable 3gv1C-5h7nA: undetectable	3gv1A-5h7nA: 17.15 3gv1C-5h7nA: 17.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GV1_B_BEZB301_0 (DISULFIDE INTERCHANGE PROTEIN)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	4 / 6	LEU A 148 ALA A 224 PRO A 126 PRO A 127	None	1.33A	3gv1A-5h7nA: undetectable 3gv1B-5h7nA: undetectable	3gv1A-5h7nA: 17.15 3gv1B-5h7nA: 17.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_1 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	12 / 12	ASP A 15 LYS A 16 LYS A 43 GLU A 45 GLU A 46 ALA A 64 ASP A 66 ARG A 67 GLU A 112 PRO A 155 TRP A 231 TYR A 342	MTT A 501 (-3.1A) MTT A 501 (-2.8A) MTT A 501 (-3.0A) MTT A 501 (-3.0A) MTT A 501 (-3.5A) MTT A 501 (-3.3A) MTT A 501 (-2.8A) MTT A 501 (-3.9A) MTT A 501 (-2.9A) MTT A 501 (-3.6A) MTT A 501 (-4.4A) MTT A 501 (-4.5A)	0.28A	3jyrA-5h7nA: 59.2	3jyrA-5h7nA: 72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	6 / 7	ASN A 13 TRP A 63 GLU A 154 TYR A 156 MET A 331 TRP A 341	MTT A 501 ( 4.8A) MTT A 501 (-4.4A) MTT A 501 (-3.5A) MTT A 501 (-3.9A) MTT A 501 ( 4.3A) MTT A 501 (-3.9A)	0.09A	3jyrA-5h7nA: 59.2	3jyrA-5h7nA: 72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JYR_A_ACRA371_2 (MALTOSE-BINDING PERIPLASMIC PROTEIN)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	6 / 7	ASN A 13 TRP A 63 TYR A 156 MET A 331 TRP A 341 ARG A 345	MTT A 501 ( 4.8A) MTT A 501 (-4.4A) MTT A 501 (-3.9A) MTT A 501 ( 4.3A) MTT A 501 (-3.9A) MTT A 501 (-3.9A)	0.57A	3jyrA-5h7nA: 59.2	3jyrA-5h7nA: 72.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N8Y_B_DIFB585_1 (PROSTAGLANDIN G/H SYNTHASE 1)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	VAL A 197 LEU A 161 GLY A 188 ALA A 189 LEU A 362	None	1.02A	3n8yB-5h7nA: undetectable	3n8yB-5h7nA: 21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OZV_B_ECNB411_1 (FLAVOHEMOGLOBIN)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 9	ILE A 162 GLN A 366 ALA A 363 LEU A 362 ALA A 163	None	1.11A	3ozvB-5h7nA: undetectable	3ozvB-5h7nA: 23.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SJ4_X_DXCX75_0 (CYTOCHROME C7)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 9	ILE A 133 LEU A 199 LYS A 257 ILE A 227 GLY A 192	None	1.22A	3sj4X-5h7nA: undetectable	3sj4X-5h7nA: 8.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	PHE A 157 GLY A 301 LEU A 300 GLU A 112 ALA A 232	None None None MTT A 501 (-2.9A) None	0.83A	3tbgB-5h7nA: undetectable	3tbgB-5h7nA: 21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	PHE A 157 GLY A 301 LEU A 300 GLU A 112 ALA A 232	None None None MTT A 501 (-2.9A) None	0.81A	3tbgD-5h7nA: undetectable	3tbgD-5h7nA: 21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TQB_A_FOLA2001_0 (DIHYDROFOLATE REDUCTASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 11	ALA A 416 LEU A 382 THR A 427 ILE A 426 LEU A 375	None	1.09A	3tqbA-5h7nA: undetectable	3tqbA-5h7nA: 15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VWQ_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	ALA A 232 TYR A 18 TYR A 211 ASN A 235 GLY A 229	None	1.36A	3vwqA-5h7nA: undetectable	3vwqA-5h7nA: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VWR_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 11	ALA A 232 ASP A 297 TYR A 211 ASN A 235 GLY A 229	None	1.29A	3vwrA-5h7nA: undetectable	3vwrA-5h7nA: 20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VYW_D_SAMD401_1 (MNMC2)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	4 / 5	GLU A 309 ASP A 315 ASP A 288 ASN A 295	None	1.37A	3vywD-5h7nA: undetectable	3vywD-5h7nA: 22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EJ1_B_FOLB201_0 (DIHYDROFOLATE REDUCTASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	ALA A 416 LEU A 382 THR A 427 ILE A 426 LEU A 375	None	1.08A	4ej1B-5h7nA: undetectable	4ej1B-5h7nA: 14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4M2X_G_TMQG202_1 (DIHYDROFOLATE REDUCTASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	ILE A 267 ALA A 106 LEU A 21 VAL A 24 ILE A 60	None	1.10A	4m2xG-5h7nA: undetectable	4m2xG-5h7nA: 16.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N48_A_SAMA601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	4 / 5	ASN A 268 ALA A 52 GLY A 57 ASP A 15	None None None MTT A 501 (-3.1A)	0.97A	4n48A-5h7nA: undetectable	4n48A-5h7nA: 21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NX7_A_FOLA202_0 (DIHYDROFOLATE REDUCTASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	ALA A 416 LEU A 382 THR A 427 ILE A 426 LEU A 375	None	1.13A	4nx7A-5h7nA: undetectable	4nx7A-5h7nA: 14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OR0_B_NPSB602_1 (SERUM ALBUMIN)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 9	ALA A 265 ALA A 106 LEU A 104 LEU A 263 VAL A 262	None	1.16A	4or0B-5h7nA: undetectable	4or0B-5h7nA: 22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P65_E_IPHE101_0 (INSULIN)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 11	ILE A 133 LEU A 140 LEU A 123 ALA A 224 LEU A 116	None	1.11A	4p65E-5h7nA: undetectable 4p65F-5h7nA: undetectable 4p65J-5h7nA: undetectable 4p65L-5h7nA: undetectable	4p65E-5h7nA: 4.35 4p65F-5h7nA: 5.88 4p65J-5h7nA: 5.88 4p65L-5h7nA: 5.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P65_K_IPHK101_0 (INSULIN)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	LEU A 116 ILE A 133 LEU A 140 LEU A 123 ALA A 224	None	1.04A	4p65F-5h7nA: undetectable 4p65H-5h7nA: undetectable 4p65K-5h7nA: undetectable 4p65L-5h7nA: undetectable	4p65F-5h7nA: 5.88 4p65H-5h7nA: 5.88 4p65K-5h7nA: 4.35 4p65L-5h7nA: 5.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QLE_A_FOLA201_0 (DIHYDROFOLATE REDUCTASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	ALA A 416 LEU A 382 THR A 427 ILE A 426 LEU A 375	None	1.08A	4qleA-5h7nA: undetectable	4qleA-5h7nA: 15.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X5G_A_FOLA201_0 (DIHYDROFOLATE REDUCTASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	ALA A 416 LEU A 382 THR A 427 ILE A 426 LEU A 375	None	1.14A	4x5gA-5h7nA: undetectable	4x5gA-5h7nA: 15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X5H_A_FOLA201_0 (DIHYDROFOLATE REDUCTASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	ALA A 416 LEU A 382 THR A 427 ILE A 426 LEU A 375	None	1.05A	4x5hA-5h7nA: undetectable	4x5hA-5h7nA: 15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	GLN A 50 ALA A 270 GLY A 55 THR A 54 ALA A 53	None	1.21A	5l66H-5h7nA: undetectable 5l66I-5h7nA: undetectable	5l66H-5h7nA: 22.22 5l66I-5h7nA: 17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	GLN A 50 ALA A 270 GLY A 55 THR A 54 ALA A 53	None	1.21A	5l66V-5h7nA: undetectable 5l66W-5h7nA: undetectable	5l66V-5h7nA: 22.22 5l66W-5h7nA: 17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LJE_A_RTLA201_1 (RETINOL-BINDING PROTEIN 1)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	4 / 6	LEU A 305 ILE A 330 THR A 94 MET A 322	None	1.29A	5ljeA-5h7nA: undetectable	5ljeA-5h7nA: 13.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC0_A_RITA602_1 (CYTOCHROME P450 3A4)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 12	PHE A 393 ILE A 179 ALA A 373 ILE A 426 ALA A 434	None	1.10A	5vc0A-5h7nA: undetectable	5vc0A-5h7nA: 23.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B58_A_ACTA603_0 (FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	3 / 3	TYR A 156 ASN A 228 LEU A 114	MTT A 501 (-3.9A) None None	0.84A	6b58A-5h7nA: undetectable	6b58A-5h7nA: 22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BM5_A_SAMA1301_0 (METHIONINE SYNTHASE)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 11	PRO A 134 GLU A 131 PRO A 255 ALA A 164 PRO A 160	None	1.46A	6bm5A-5h7nA: undetectable	6bm5A-5h7nA: 22.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_V_BO2V301_0 (PROTEASOME SUBUNIT BETA TYPE-2)	5h7n	NLRP12-PYD WITH MBP TAG (Homo sapiens)	5 / 11	GLN A 366 ALA A 365 ALA A 163 GLY A 167 ALA A 189	None	1.10A	6hwdV-5h7nA: undetectable	6hwdV-5h7nA: 10.62

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1E06_A_IPBA600_0","ODORANT-BINDING PROTEIN","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",4,"VAL A   9;VAL A  51;ILE A  61;ASN A 268","None","0.91A","1e06A-5h7nA:undetectable","1e06A-5h7nA:15.70"],["1KGL_A_RTLA175_1","CELLULAR RETINOL-BINDING PROTEIN TYPE I","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",4,"LEU A 305;ILE A 330;THR A  94;MET A 322","None","1.22A","1kglA-5h7nA:undetectable","1kglA-5h7nA:13.57"],["2H42_A_VIAA901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ALA A 304;ILE A 109;VAL A  98;LEU A  77;ILE A  80","None","1.26A","2h42A-5h7nA:undetectable","2h42A-5h7nA:21.61"],["2H42_C_VIAC903_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"LEU A 263;ILE A 109;VAL A  98;LEU A  77;ILE A  80","None","0.95A","2h42C-5h7nA:undetectable","2h42C-5h7nA:21.61"],["2QD2_A_CHDA426_0","FERROCHELATASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",4,"LEU A 382;PRO A 418;LEU A 390;ARG A 447","None;EDO A 506 (-4.1A);None;None","1.38A","2qd2A-5h7nA:undetectable","2qd2A-5h7nA:20.69"],["2VE3_A_REAA1445_1","PUTATIVE CYTOCHROME P450 120","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ALA A 265;LEU A 281;PHE A 280;VAL A 294;GLY A  17","None","1.11A","2ve3A-5h7nA:undetectable","2ve3A-5h7nA:22.30"],["2ZW9_A_SAMA801_1","LEUCINE CARBOXYL METHYLTRANSFERASE 2","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",4,"THR A  94;LEU A 286;ASP A 288;GLU A 112","None;None;None;MTT A 501 (-2.9A)","1.07A","2zw9A-5h7nA:undetectable","2zw9A-5h7nA:20.97"],["3BGD_A_PM6A301_1","THIOPURINE S-METHYLTRANSFERASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",4,"PHE A 259;ALA A 163;LEU A 248;PRO A 160","EDO A 505 (-4.9A);None;None;None","0.98A","3bgdA-5h7nA:undetectable","3bgdA-5h7nA:19.87"],["3BJW_C_SVRC507_1","PHOSPHOLIPASE A2","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",4,"VAL A 111;GLY A 301;PRO A 230;LYS A 306","None","0.72A","3bjwC-5h7nA:undetectable","3bjwC-5h7nA:15.11"],["3GV1_A_BEZA302_0","DISULFIDE INTERCHANGE PROTEIN","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",4,"PRO A 127;LEU A 148;ALA A 224;PRO A 126","None","1.34A","3gv1A-5h7nA:undetectable;3gv1C-5h7nA:undetectable","3gv1A-5h7nA:17.15;3gv1C-5h7nA:17.15"],["3GV1_B_BEZB301_0","DISULFIDE INTERCHANGE PROTEIN","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",4,"LEU A 148;ALA A 224;PRO A 126;PRO A 127","None","1.33A","3gv1A-5h7nA:undetectable;3gv1B-5h7nA:undetectable","3gv1A-5h7nA:17.15;3gv1B-5h7nA:17.15"],["3JYR_A_ACRA371_1","MALTOSE-BINDING PERIPLASMIC PROTEIN","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",12,"ASP A  15;LYS A  16;LYS A  43;GLU A  45;GLU A  46;ALA A  64;ASP A  66;ARG A  67;GLU A 112;PRO A 155;TRP A 231;TYR A 342","MTT A 501 (-3.1A);MTT A 501 (-2.8A);MTT A 501 (-3.0A);MTT A 501 (-3.0A);MTT A 501 (-3.5A);MTT A 501 (-3.3A);MTT A 501 (-2.8A);MTT A 501 (-3.9A);MTT A 501 (-2.9A);MTT A 501 (-3.6A);MTT A 501 (-4.4A);MTT A 501 (-4.5A)","0.28A","3jyrA-5h7nA:59.2","3jyrA-5h7nA:72.73"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",6,"ASN A  13;TRP A  63;GLU A 154;TYR A 156;MET A 331;TRP A 341","MTT A 501 ( 4.8A);MTT A 501 (-4.4A);MTT A 501 (-3.5A);MTT A 501 (-3.9A);MTT A 501 ( 4.3A);MTT A 501 (-3.9A)","0.09A","3jyrA-5h7nA:59.2","3jyrA-5h7nA:72.73"],["3JYR_A_ACRA371_2","MALTOSE-BINDING PERIPLASMIC PROTEIN","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",6,"ASN A  13;TRP A  63;TYR A 156;MET A 331;TRP A 341;ARG A 345","MTT A 501 ( 4.8A);MTT A 501 (-4.4A);MTT A 501 (-3.9A);MTT A 501 ( 4.3A);MTT A 501 (-3.9A);MTT A 501 (-3.9A)","0.57A","3jyrA-5h7nA:59.2","3jyrA-5h7nA:72.73"],["3N8Y_B_DIFB585_1","PROSTAGLANDIN G\/H SYNTHASE 1","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"VAL A 197;LEU A 161;GLY A 188;ALA A 189;LEU A 362","None","1.02A","3n8yB-5h7nA:undetectable","3n8yB-5h7nA:21.04"],["3OZV_B_ECNB411_1","FLAVOHEMOGLOBIN","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ILE A 162;GLN A 366;ALA A 363;LEU A 362;ALA A 163","None","1.11A","3ozvB-5h7nA:undetectable","3ozvB-5h7nA:23.99"],["3SJ4_X_DXCX75_0","CYTOCHROME C7","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ILE A 133;LEU A 199;LYS A 257;ILE A 227;GLY A 192","None","1.22A","3sj4X-5h7nA:undetectable","3sj4X-5h7nA:8.37"],["3TBG_B_RTZB1_1","CYTOCHROME P450 2D6","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"PHE A 157;GLY A 301;LEU A 300;GLU A 112;ALA A 232","None;None;None;MTT A 501 (-2.9A);None","0.83A","3tbgB-5h7nA:undetectable","3tbgB-5h7nA:21.74"],["3TBG_D_RTZD1_1","CYTOCHROME P450 2D6","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"PHE A 157;GLY A 301;LEU A 300;GLU A 112;ALA A 232","None;None;None;MTT A 501 (-2.9A);None","0.81A","3tbgD-5h7nA:undetectable","3tbgD-5h7nA:21.74"],["3TQB_A_FOLA2001_0","DIHYDROFOLATE REDUCTASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ALA A 416;LEU A 382;THR A 427;ILE A 426;LEU A 375","None","1.09A","3tqbA-5h7nA:undetectable","3tqbA-5h7nA:15.77"],["3VWQ_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ALA A 232;TYR A  18;TYR A 211;ASN A 235;GLY A 229","None","1.36A","3vwqA-5h7nA:undetectable","3vwqA-5h7nA:20.70"],["3VWR_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ALA A 232;ASP A 297;TYR A 211;ASN A 235;GLY A 229","None","1.29A","3vwrA-5h7nA:undetectable","3vwrA-5h7nA:20.49"],["3VYW_D_SAMD401_1","MNMC2","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",4,"GLU A 309;ASP A 315;ASP A 288;ASN A 295","None","1.37A","3vywD-5h7nA:undetectable","3vywD-5h7nA:22.24"],["4EJ1_B_FOLB201_0","DIHYDROFOLATE REDUCTASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ALA A 416;LEU A 382;THR A 427;ILE A 426;LEU A 375","None","1.08A","4ej1B-5h7nA:undetectable","4ej1B-5h7nA:14.44"],["4M2X_G_TMQG202_1","DIHYDROFOLATE REDUCTASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ILE A 267;ALA A 106;LEU A  21;VAL A  24;ILE A  60","None","1.10A","4m2xG-5h7nA:undetectable","4m2xG-5h7nA:16.53"],["4N48_A_SAMA601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",4,"ASN A 268;ALA A  52;GLY A  57;ASP A  15","None;None;None;MTT A 501 (-3.1A)","0.97A","4n48A-5h7nA:undetectable","4n48A-5h7nA:21.41"],["4NX7_A_FOLA202_0","DIHYDROFOLATE REDUCTASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ALA A 416;LEU A 382;THR A 427;ILE A 426;LEU A 375","None","1.13A","4nx7A-5h7nA:undetectable","4nx7A-5h7nA:14.44"],["4OR0_B_NPSB602_1","SERUM ALBUMIN","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ALA A 265;ALA A 106;LEU A 104;LEU A 263;VAL A 262","None","1.16A","4or0B-5h7nA:undetectable","4or0B-5h7nA:22.74"],["4P65_E_IPHE101_0","INSULIN","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ILE A 133;LEU A 140;LEU A 123;ALA A 224;LEU A 116","None","1.11A","4p65E-5h7nA:undetectable;4p65F-5h7nA:undetectable;4p65J-5h7nA:undetectable;4p65L-5h7nA:undetectable","4p65E-5h7nA:4.35;4p65F-5h7nA:5.88;4p65J-5h7nA:5.88;4p65L-5h7nA:5.88"],["4P65_K_IPHK101_0","INSULIN","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"LEU A 116;ILE A 133;LEU A 140;LEU A 123;ALA A 224","None","1.04A","4p65F-5h7nA:undetectable;4p65H-5h7nA:undetectable;4p65K-5h7nA:undetectable;4p65L-5h7nA:undetectable","4p65F-5h7nA:5.88;4p65H-5h7nA:5.88;4p65K-5h7nA:4.35;4p65L-5h7nA:5.88"],["4QLE_A_FOLA201_0","DIHYDROFOLATE REDUCTASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ALA A 416;LEU A 382;THR A 427;ILE A 426;LEU A 375","None","1.08A","4qleA-5h7nA:undetectable","4qleA-5h7nA:15.09"],["4X5G_A_FOLA201_0","DIHYDROFOLATE REDUCTASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ALA A 416;LEU A 382;THR A 427;ILE A 426;LEU A 375","None","1.14A","4x5gA-5h7nA:undetectable","4x5gA-5h7nA:15.25"],["4X5H_A_FOLA201_0","DIHYDROFOLATE REDUCTASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"ALA A 416;LEU A 382;THR A 427;ILE A 426;LEU A 375","None","1.05A","4x5hA-5h7nA:undetectable","4x5hA-5h7nA:15.25"],["5L66_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"GLN A  50;ALA A 270;GLY A  55;THR A  54;ALA A  53","None","1.21A","5l66H-5h7nA:undetectable;5l66I-5h7nA:undetectable","5l66H-5h7nA:22.22;5l66I-5h7nA:17.84"],["5L66_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"GLN A  50;ALA A 270;GLY A  55;THR A  54;ALA A  53","None","1.21A","5l66V-5h7nA:undetectable;5l66W-5h7nA:undetectable","5l66V-5h7nA:22.22;5l66W-5h7nA:17.84"],["5LJE_A_RTLA201_1","RETINOL-BINDING PROTEIN 1","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",4,"LEU A 305;ILE A 330;THR A  94;MET A 322","None","1.29A","5ljeA-5h7nA:undetectable","5ljeA-5h7nA:13.67"],["5VC0_A_RITA602_1","CYTOCHROME P450 3A4","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"PHE A 393;ILE A 179;ALA A 373;ILE A 426;ALA A 434","None","1.10A","5vc0A-5h7nA:undetectable","5vc0A-5h7nA:23.54"],["6B58_A_ACTA603_0","FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",3,"TYR A 156;ASN A 228;LEU A 114","MTT A 501 (-3.9A);None;None","0.84A","6b58A-5h7nA:undetectable","6b58A-5h7nA:22.20"],["6BM5_A_SAMA1301_0","METHIONINE SYNTHASE","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"PRO A 134;GLU A 131;PRO A 255;ALA A 164;PRO A 160","None","1.46A","6bm5A-5h7nA:undetectable","6bm5A-5h7nA:22.45"],["6HWD_V_BO2V301_0","PROTEASOME SUBUNIT BETA TYPE-2","5h7n","NLRP12-PYD WITH MBP TAG","Homo sapiens",5,"GLN A 366;ALA A 365;ALA A 163;GLY A 167;ALA A 189","None","1.10A","6hwdV-5h7nA:undetectable","6hwdV-5h7nA:10.62"]]